Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
- Why CMC Must Shape Critical Decisions Early In Development
- Closing The Gap Between Modeling And GMP Predictive Control
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- IT/OT Convergence Could Lighten Biopharma's Automation Burden
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- Want More Sustainable Biopharma Packaging? Try These Levers
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
EDITOR'S DESK
-
Contextualizing Data To Enable AI And Prevent Knowledge Leaks
Bioprocess Online's Tyler Menichiello interviews Martin Kockx, a principal manufacturing systems engineer at Vertex Pharmaceuticals, on his presentation at 2026 BPI, “Transforming Biomanufacturing: Why Architecture Must Precede Analytics."
An interview with Jacqualyn Schulman, Ph.D., a principal scientist at Bristol Myers Squibb (BMS), on her presentation at BPI 2026, “Fast-Tracking CHO Cell Line Development Using Integrated Engineering Strategies.”
This article captures key takeaways from a BioProcess International keynote by Preeya Boppana, director of MSAT process analytics and laboratories at AstraZeneca, titled “Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations.”
Regulatory compliance and cGMP manufacturing expert Tatyana Matveeva, Ph.D., explains the role and importance of a quality unit in an organization, as well as what happens when it’s compromised.
Experts discuss where productivity gains can be achieved and how development teams should seek to improve process performance in this recap of the Bioprocess Online Live event "The Levers And Tradeoffs That Drive Process Productivity."
GUEST COLUMNISTS
-
Developing Your Vapor Phase Hydrogen Peroxide Cycle
Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.
-
Closing The Gap Between Modeling And GMP Predictive Control
Predictive control offers opportunities to improve process consistency, reduce variability, and respond to changing manufacturing conditions before they cause deviations.
-
IT/OT Convergence Could Lighten Biopharma's Automation Burden
Integration lets frameworks talk to each other through middleware. Convergence brings them under the same architecture, which can can reduce costs and maintenance.
-
Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
Determining whether a drug manufacturing environment is stable, drifting, or developing a recurring loss-of-control signal requires integrated trend evaluation.
-
Want More Sustainable Biopharma Packaging? Try These Levers
Biopharmaceutical packaging optimization must not compromise the goods inside or compliance, so sustainable packaging developers might need to think outside the box.
-
What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know.
-
How To Keep Your 'Big Bang' Platform Switch From Becoming A Big Bust
Leaders at a Roche fill/finish facility describe the tactile steps involve to change EMS, ERP, and WMS all at once with no rollback option.
-
How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
Europe's glass manufacturers, including those making pharmaceutical lab glassware, have experienced a series of energy shocks. Many have adopted sustainability practices.
BIOPROCESSING WHITE PAPERS
-
Perfusion Cell Line Development For Intensified Processes
The biopharmaceutical industry is transforming by shifting to continuous and intensified upstream bioprocesses, which are driven by evolving demands. Discover the key goals and innovations shaping this transition for modern healthcare.
-
Where Innovation And Investment Reduce Drug Development Risk6/12/2026
How strategic investments in development, manufacturing, and clinical supply are helping organizations reduce risk and accelerate drug development.
-
Where Speed Meets Complexity In Bioprocess Development6/18/2026
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
Why The Traditional Approach To Evaluating Gene Editing Is Not Your Only Option9/7/2026
De-risk genetic medicine development with a phased evaluation approach. Gain rapid, data-driven feasibility insights before major investments, enabling smarter decisions and faster clinical progress.
-
Three Steps To Digital Transformation In Life Sciences Manufacturing1/30/2025
Explore trends that are transforming the industry, some common speedbumps on the road to innovation, and how a new platform offers unprecedented process transparency and continuous improvement.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
BIOPROCESSING APP NOTES & CASE STUDIES
- The Real Value Of Continuous Bioprocessing Is In Connected Unit Operations
- On The Ground At BPI: Where AI Dreams Meet Operational Reality
- On The Ground At BPI: Tatyana Matveeva, Ph.D., On Distributed Manufacturing Models
- Contextualizing Data To Enable AI And Prevent Knowledge Leaks
- On The Ground At BPI: Jacqualyn Schulman, Ph.D., On Accelerating Clonal CLD
- AstraZeneca's Focus On Predictive Control, Semi-Autonomous Processing
- Prioritizing Quality Over Everything
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Editorial Collections are subscriber-only, curated resources that combine expert interviews, feature articles, and industry analysis to help readers better understand emerging trends, operational challenges, regulatory developments, and best practices shaping the biopharma industry.
More Editorial CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Planning For Scale From The Start: Where Early Development Decisions Create Commercial Risk
- Intensifying CHO Fed-Batch With N-1 Perfusion: 14 To 10 Days
- The Critical Role Of Integrated Handling Design
- Decoding Biologic Performance: Combining SPR And Cell-Based Assays To Drive Development Decisions
- Rethinking Facility Design For The Reality Of Complex Biologics
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.18.26 -- Is It Time To Rethink Your Protein Expression Strategy?
- 11.18.26 -- Will Your Next-Gen Conjugate Survive Scale-Up?
- 11.18.26 -- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- 11.17.26 -- Turning Data Into Development Confidence
- 11.17.26 -- New Resources To Support Your Cell Factory Scale-Up

